For research use only. Not for therapeutic Use.
Ficonalkib is a potent inhibitor of Anaplastic lymphoma kinase (ALK), the tyrosine kinase receptor. Ficonalkib, can be used as an antineoplastic agent[1][2].
| Catalog Number | I041946 |
| CAS Number | 2233574-95-1 |
| Synonyms | 2-N-[4-[4-(dimethylamino)piperidin-1-yl]-2-methoxyphenyl]-4-N-(2-propan-2-ylsulfonylphenyl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine-2,4-diamine |
| Molecular Formula | C29H39N7O3S |
| Purity | ≥95% |
| InChI | InChI=1S/C29H39N7O3S/c1-19(2)40(37,38)26-9-7-6-8-24(26)31-28-22-12-15-30-27(22)33-29(34-28)32-23-11-10-21(18-25(23)39-5)36-16-13-20(14-17-36)35(3)4/h6-11,18-20H,12-17H2,1-5H3,(H3,30,31,32,33,34) |
| InChIKey | LDTJJGGYLQQRSP-UHFFFAOYSA-N |
| SMILES | CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC3=C2CCN3)NC4=C(C=C(C=C4)N5CCC(CC5)N(C)C)OC |
| Reference | [1]. Liu Guocheng, et al. Preparation of anaplastic lymphoma kinase inhibitor: China, CN108276410. 2018-07-13. [2]. WHO Drug Information-World Health Organization (WHO). |
